Corporate ActionJun 18, 2026, 05:12 PM
bioAffinity Technologies Closes $3.2M Public Offering
AI Summary
bioAffinity Technologies, Inc. completed a public offering, raising approximately $3.2 million in gross proceeds. The offering included 1,040,000 shares of common stock at $0.80 per share and pre-funded warrants to purchase up to 2,960,000 shares at $0.793 per warrant. The company intends to use the net proceeds for working capital and general corporate purposes. WallachBeth Capital LLC acted as the sole placement agent, receiving a 7.5% fee and $120,000 in expense reimbursement.
Key Highlights
- Closed public offering raising approximately $3.2 million in gross proceeds.
- Offered 1,040,000 shares of common stock at $0.80 per share.
- Offered pre-funded warrants for up to 2,960,000 shares at $0.793 per warrant.
- Pre-funded warrants are immediately exercisable at $0.007 per share.
- Proceeds to be used for working capital and general corporate purposes.
- Paid WallachBeth Capital LLC a 7.5% fee and $120,000 in expenses.
- Company and insiders subject to 30-day lock-up on securities issuance.
Price Impact
More from BIAF